WHAT WE DO
IEM can quickly harness and mobilize resources to establish and operate COVID-19 Testing Program Management & Logistics Services.
As a disaster and crisis response and recovery firm, IEM assists all levels of government and the private sector on those occasions where their resources are overwhelmed or not adequate to meet the demands. Often IEM’s resources are utilized for short-duration events where it makes more sense to hire a private company than it does to hire government employees. We are able to quickly hire, train and deploy personnel, complete the mission, and demobilize.
As a company, IEM has responded to nearly every major disaster, including COVID, deploying personnel to support national hotspots. We are capable of standing up operations within 24 hours, providing logistical and planning support for the tracking and administering of medical testing and disaster relief supplies and workers.
IEM’s extensive program management experience coupled with our health care expertise and readily available qualified pool of medical personnel ensures successful management and support of surge operations for COVID-19 testing.
IEM MED Background
IEM has supported medical and public health planning for more than 20 years. This work has helped the U.S. Federal government, the Department of Defense (DOD), as well as state and local agencies better prepare for and respond to bioterrorism scenarios, such as Anthrax and Smallpox, emerging infectious diseases, including Ebola ad Zika, and pandemics such as the 2009 H1N1 influenza pandemic and the current COVID-19 pandemic.
IEM is working daily to collect and analyze data on COVID-19 cases in each U.S. state and over 400 major counties. This AI-based model is meant to help medical and public health planners better understand the upcoming medical demands for their locale and to plan accordingly.
IEM Medical Director, Dr. Rashid Chotani has led outbreak investigation and contact tracing into various disease outbreaks. He worked as an expert in identification, surveillance, and diagnosis of human and zoonotic infectious diseases, such as brucellosis, anthrax, plague, and hemorrhagic and viral diseases. He has applied his depth of expertise in these areas to develop ground-breaking research and development programs and to advance development of vaccines, therapeutics, and diagnostics for chemical and biological threats.